Metacognitive Intervention for Individuals With Severe Mental Disorders

University of Haifa84 enrolled

Overview

The overall aim of this study was to develop a meta-cognitive group intervention in order to apply it and to understand and distinguish the components that influence participation among people with schizophrenia

The overall aim of this study was to develop a Meta cognitive group intervention in order to apply it and to understand and distinguish the components that influence participation among people with schizophrenia. The specific objectives were to: 1. Improve participation by increasing the effectiveness of cognitive strategy use and teaching clients to independently review performance and to examine the strategy's effectiveness. 2. Compare the use of cognitive strategies between participants with schizophrenia and their matched controls following the Meta cognitive group intervention and to correlate the cognitive strategies use and participation following the Meta cognitive group. 3. Examine whether symptoms moderate the association between metacognitive outcomes and participation among people with schizophrenia following the Meta cognitive group.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Schizophrenia

Interventions

Metacognitive Group InterventionBEHAVIORAL

The investigators developed an initial Meta cognitive group intervention protocol based on the dynamic interactional model of cognition (Toglia, 2005), and specifically tailored it to individuals with schizophrenia.

Occupational therapy standard careBEHAVIORAL

Occupational therapy standard care

Eligibility

Sex: ALLMin age: 23 YearsMax age: 68 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Confirmed diagnosis of schizophrenia by a licensed psychiatrist * Fluency in Hebrew * t-score of at least 65 on the Behavior Rating Inventory of Executive Function-Adult version Exclusion Criteria: * Severe psychiatric hospitalization of over 24 hours during the month prior to the beginning of the study * Used drugs or alcohol

Outcomes

Primary Outcomes

Positive and Negative Syndrome Scale

The Positive and Negative Syndrome Scale is a 30-item scale with seven positive and seven negative symptoms items and 16 psychopathological items. The severity of each item is rated on a scale from 1 (none) to 7 (most severe). A general Positive and Negative Syndrome Scale score is between 30 (lack of symptoms) and 210 (very severe state of the disease). Potential ranges are 7 to 49 for the positive and negative symptom scales and from 16 to 12 for the general psychopathology scale.

Time frame: 15 minutes

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.